csDMARDlääkkeistä
csDMARDlääkkeet, or conventional synthetic disease-modifying antirheumatic drugs, are a cornerstone in the management of inflammatory autoimmune diseases, particularly rheumatoid arthritis. These medications work by modulating the immune system to reduce inflammation and slow down or halt the progression of joint damage. Unlike medications that only treat symptoms, csDMARDs target the underlying disease process.
The most common csDMARD is methotrexate, which is often the first-line treatment for rheumatoid arthritis. Other